scholarly journals Circulating microRNAs in serum as novel biomarkers for osteoporosis: a case-control study

2020 ◽  
Vol 12 ◽  
pp. 1759720X2095333
Author(s):  
Yi Shuai ◽  
Li Liao ◽  
Xiaoxia Su ◽  
Nanxi Sha ◽  
Xiaobo Li ◽  
...  

Aims: Osteoporosis is underdiagnosed because of the lack of a convenient diagnostic method. Circulating microRNAs (miRNAs) emerge as novel biomarkers for disease diagnosis. Here, we conducted a case-control study that included a total of 448 serum samples collected from 182 healthy participants, 132 osteopenia participants, and 134 osteoporosis patients. Methods: Circulating miRNAs dysregulated during osteoporosis were screened and analyzed in three randomly determined sub-cohorts: the discovery cohort identified 22 candidate miRNAs; the training cohort tested the candidate miRNAs and constructed Index 1, comprising five miRNAs by logistic regression, and Index 2, comprising four miRNAs, was developed by linear combination. Results: Both indices were tested in the validation cohort and showed statistically significant results in distinguishing osteoporosis patients from healthy and osteopenic patients. Moreover, Index 1 also showed improved performance over traditional bone turnover biomarkers type I pro-collagen (tPINP) and type I collagen (β-CTx). Conclusion: In conclusion, circulating miRNAs are potential biomarkers for osteoporosis. The diagnostic panel of circulating miRNAs could be a complementary method for dual-energy X-ray absorptiometry (DXA) in mass screening and routine examination to enhance the osteoporosis detection rate.

Neurology ◽  
1997 ◽  
Vol 49 (6) ◽  
pp. 1546-1551 ◽  
Author(s):  
J.S.P. van den Berg ◽  
M. Limburg ◽  
G. Pals ◽  
F. Arwert ◽  
A. Westerveld ◽  
...  

2018 ◽  
Vol 56 (1) ◽  
pp. 55-65 ◽  
Author(s):  
Taís S. Assmann ◽  
Mariana Recamonde-Mendoza ◽  
Aline R. Costa ◽  
Márcia Puñales ◽  
Balduíno Tschiedel ◽  
...  

2017 ◽  
Vol 11 (03) ◽  
pp. 340-344 ◽  
Author(s):  
Piero Papi ◽  
Stefano Di Carlo ◽  
Daniele Rosella ◽  
Francesca De Angelis ◽  
Mario Capogreco ◽  
...  

ABSTRACT Objective: The aim of this case–control study was to compare patients with a healthy peri-implant environment and patients affected by peri-implantitis, evaluating the occurrence of antibodies to extracellular matrix (ECM) molecules. The authors hypothesized the presence of ECM autoantibodies in serum of peri-implantitis patients. Materials and Methods: Patients were divided into two groups: one with dental implants with a diagnosis of peri-implantitis and one control group with implants classified as being “healthy.” Enzyme-linked immunosorbent assay was performed on patients' sera to detect human antibodies to type I, III, IV, and V collagens, laminin, and fibronectin. Fisher exact test was performed to evaluate statistical association, with a significant P < 0.05. Results: Forty-two patients were enrolled in this study, 27 females (64.28%) and 15 males (35.72%) with a mean age of 53 ± 29.69 years (age range 32–74). The presence of antibodies to CIII was recorded in 6/21 (28.57%) patients of test group, compared to just 2/21 (9.52%) for the control group, showing a statistically significant difference (P < 0.05). Other antibodies tested were found to be not statistically significant or absent. Conclusions: Within the limitations of this study, it can be concluded that further studies, with larger sample and different design, are necessary to address the research purpose, evaluating possible associations between anti-ECM antibodies and peri-implantitis.


PLoS ONE ◽  
2015 ◽  
Vol 10 (10) ◽  
pp. e0139981 ◽  
Author(s):  
Daniel D. Murray ◽  
Kazuo Suzuki ◽  
Matthew Law ◽  
Jonel Trebicka ◽  
Jacquie Neuhaus ◽  
...  

2002 ◽  
Vol 18 (5) ◽  
pp. 425-430 ◽  
Author(s):  
Emma Altobelli ◽  
Reimondo Petrocelli ◽  
Alberto Verrotti ◽  
Marco Valenti

eLife ◽  
2021 ◽  
Vol 10 ◽  
Author(s):  
Chiara Fallerini ◽  
Sergio Daga ◽  
Stefania Mantovani ◽  
Elisa Benetti ◽  
Nicola Picchiotti ◽  
...  

Background: Recently, loss-of-function variants in TLR7 were identified in two families in which COVID-19 segregates like an X-linked recessive disorder environmentally conditioned by SARS-CoV-2. We investigated whether the two families represent the tip of the iceberg of a subset of COVID-19 male patients. Methods: This is a nested case-control study in which we compared male participants with extreme phenotype selected from the Italian GEN-COVID cohort of SARS-CoV-2-infected participants (<60y, 79 severe cases versus 77 control cases). We applied the LASSO Logistic Regression analysis, considering only rare variants on young male subsets with extreme phenotype, picking up TLR7 as the most important susceptibility gene. Results: Overall, we found TLR7 deleterious variants in 2.1% of severely affected males and in none of the asymptomatic participants. The functional gene expression profile analysis demonstrated a reduction in TLR7-related gene expression in patients compared with controls demonstrating an impairment in type I and II IFN responses. Conclusion: Young males with TLR7 loss-of-function variants and severe COVID-19 represent a subset of male patients contributing to disease susceptibility in up to 2% of severe COVID-19.


Sign in / Sign up

Export Citation Format

Share Document